Biotech News: Mirror to Biotech Academia & Industry

Biotech news from India and across the globe. One stop site for your daily dose of Biotech industry , academia news and latest collaborations

Dear CSIR NET Aspirants,

Swiss drugmaker Novartis announced a multi-billion dollar renovation by exchanging assets with GlaxoSmithKline and selling its animal health unit.

Aastrom Biosciences is buying Sanofi's Cell Therapy and Regenerative Medicine (CTRM) business for $6.5 million, thus gaining global commercial rights to three autologous cell therapy pr

India and Argentina will soon begin joint research in different scientific areas such as biotechnology (including drug discovery), medical sciences and health.

The London based asthma & heart drug maker, AstraZeneca is being rumored to be acquired by the world's largest drugmaker, Pfizer in a deal worth $101 billion.

For the first time, scientists have found an Earth-sized planet orbiting in a life-friendly zone around a distant star. This star, known as Kepler-186 and located about 500 light

Novartis has achieved the top spot on Modern Healthcare's annual list of largest publicly traded pharmaceutical companies, leaving behind Pfizer.

Scientists are now a step closer to the goal of creating stem cells which are perfectly matched to a patient's DNA in order to treat diseases by creating patient-specific cell lines out

Researchers have sequenced the entire genome and all the RNA products of the most deadly pathogenic lineage of Cryptococcus neoformans, a strain called H99.

DNA nanorobots have already proven their drug-delivering performance in early in vitro clinical trials.

Nasa is all set to send the largest ever plant growth chamber to the International Space Station (ISS). Astronauts will now grow lettuce in space ! The US space agency will

Scientists from North Carolina State University, UNC-Chapel Hill, and other institutions have mentioned that they have taken the first steps toward creating a roadmap that may help scientis

Japanese pharmaceutical major Takeda was imposed the largest fine ever in pharmaceutical world for hiding cancer risks associated with Actos, a bestselling diabetes drug.

Researchers at the University of Edinburgh and the Scottish National Blood Transfusion Service (SNBTS) will assess how well people accept blood transfusions derived from induced pluripotent

The French Competition Authority accelerated its investigation of potential Lucentis price-fixing, by raiding local offices of Roche and Novartis, looking for evidence of collusion.

Ranbaxy saw some good news from the US drug regulator just days before the announcement of its acquisition by Sun Pharmaceutical in a $4-billion deal inclusive of debt. The deal betwee

GlaxoSmithKline's immunotherapy team suits up for the last big slot in an ambitious alliance of industry giants aimed at discovering some new products in the red-hot cancer R&D fiel

A team of scientists at University of Edinburgh have been able to fully restore an organ in a living animal for the first time.

The Department of Biotechnology (DBT) will soon initiate several measures for building world-class human capital and will nurture an outstanding workforce as well as leadership for R&D

Sun Pharmaceutical Industries will completely acquire perturbed Ranbaxy Laboratories, in an all-stock transaction with a total equity value of $3.2 billion. The combination of Sun

The Union Government has modified the rules under the 'Transplantation of Human Organs Act' and notified the same with a view to widen the donor pool by including grandparents and g

Leading Indian drug company Biocon rejected allegations by Novartis that it infringed on the Swiss pharmaceutical giant's patent for its blockbuster diabetes drug Galvus.

 Global CROs, international research centres & leading bio pharma companies are pooling in India, contemplating on the kick start of human studies.

(Reuters) - Novartis has taken India's Biocon to court for infringing the patent on its diabetes drug Galvus, the Swiss drugmaker said in a statement on Thursday.